RS49628B - Medicinski aerosolni proizvodi - Google Patents

Medicinski aerosolni proizvodi

Info

Publication number
RS49628B
RS49628B YUP-598/99A YU59899A RS49628B RS 49628 B RS49628 B RS 49628B YU 59899 A YU59899 A YU 59899A RS 49628 B RS49628 B RS 49628B
Authority
RS
Serbia
Prior art keywords
aerosol products
medicinal aerosol
butyl
formula
heptafluoropropane
Prior art date
Application number
YUP-598/99A
Other languages
English (en)
Inventor
Martin J. Oliver
Kanu M. Fatania
John S. Scott
Helgert Muller
Original Assignee
Altana Pharma Ag.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710496.2A external-priority patent/GB9710496D0/en
Priority claimed from GBGB9803990.2A external-priority patent/GB9803990D0/en
Application filed by Altana Pharma Ag., filed Critical Altana Pharma Ag.,
Publication of YU59899A publication Critical patent/YU59899A/sh
Publication of RS49628B publication Critical patent/RS49628B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

Farmaceutska kompozicija koja sadrži terapeutski efikasnu količinu jedinjenja Formule: (I) u kojoj: R1 jeste 1-butil, 2-butil, cikloheksil ili fenil, a R2 je acetil ili izobutanoil grupa, i propelent odabran između 1,1,1,2-tetrafluoroetana, 1,1,1,2,3,3,3-heptafluoropropana i njihove smeše, i etanol u količini efikasnoj da rastvori jedinejnje formule (I) i, u datom slučaju, površinski aktivnu supstancu. Prijava sadrži još 1 nezavisan zahtev i 15 zavisnih patentnih zahteva.
YUP-598/99A 1997-05-21 1998-05-18 Medicinski aerosolni proizvodi RS49628B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710496.2A GB9710496D0 (en) 1997-05-21 1997-05-21 Medicinal aerosol products
GBGB9803990.2A GB9803990D0 (en) 1998-02-25 1998-02-25 Medicinal aerosol products

Publications (2)

Publication Number Publication Date
YU59899A YU59899A (sh) 2002-06-19
RS49628B true RS49628B (sr) 2007-08-03

Family

ID=26311564

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-598/99A RS49628B (sr) 1997-05-21 1998-05-18 Medicinski aerosolni proizvodi

Country Status (28)

Country Link
US (1) US6120752A (sr)
EP (1) EP0983058B1 (sr)
JP (4) JP2001526685A (sr)
KR (1) KR100527643B1 (sr)
CN (1) CN1149073C (sr)
AT (1) ATE245966T1 (sr)
AU (1) AU726835B2 (sr)
BG (1) BG64268B1 (sr)
BR (1) BR9809448A (sr)
CA (1) CA2290521C (sr)
CZ (1) CZ298253B6 (sr)
DE (1) DE69816811T2 (sr)
DK (1) DK0983058T3 (sr)
EA (1) EA002381B1 (sr)
ES (1) ES2205491T3 (sr)
HK (1) HK1027027A1 (sr)
HU (1) HU226694B1 (sr)
IL (1) IL132738A (sr)
ME (1) ME01631B (sr)
NO (2) NO327716B1 (sr)
NZ (1) NZ500874A (sr)
PL (1) PL191523B1 (sr)
PT (1) PT983058E (sr)
RS (1) RS49628B (sr)
SK (1) SK283930B6 (sr)
TR (1) TR199902863T2 (sr)
UA (1) UA58551C2 (sr)
WO (1) WO1998052542A1 (sr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
WO2004033478A2 (en) * 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
KR101235583B1 (ko) * 2002-10-25 2013-02-22 허니웰 인터내셔널 인코포레이티드 플루오린 치환된 올레핀을 함유하는 조성물
JP4755495B2 (ja) * 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
US8435497B2 (en) 2003-06-13 2013-05-07 Takeda Gmbh Formoterol of and ciclesonide combination
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
GB2406283B (en) 2003-09-24 2006-04-05 Altana Pharma Ag Compliance monitor and method
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2550811C (en) * 2003-12-24 2012-05-01 Jane Hirsh Temperature-stable formulations, and methods of development thereof
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
WO2006027377A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
CN103462894A (zh) * 2005-03-16 2013-12-25 霍尼韦尔国际公司 药物递送制剂、装置和方法
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
EP2120875B1 (en) 2007-02-11 2018-07-11 Map Pharmaceuticals Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
ES2471145T3 (es) * 2009-03-09 2014-06-25 Mikasa Seiyaku Co,. Ltd. Compuesto esteroide
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
KR20180028563A (ko) * 2010-10-12 2018-03-16 시플라 리미티드 약학 조성물
CA2844944A1 (en) 2011-08-18 2013-02-21 Takeda Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation
CN102335132A (zh) * 2011-10-12 2012-02-01 中山大学 一种细辛脑吸入气雾剂及其制备方法
EP2809780B1 (en) 2012-02-01 2018-05-02 Protalix Ltd. Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077229B (en) * 1980-05-16 1983-08-03 Neotechnic Eng Ltd Valve assembly for a pressurized aerosoldispensing container
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
ES2071306T3 (es) * 1990-03-23 1995-06-16 Minnesota Mining & Mfg El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
WO1992006675A1 (en) * 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
EP0735884B1 (en) * 1993-12-20 2000-04-26 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
NZ306280A (en) * 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler for salmeterol
JP3573213B2 (ja) * 1995-04-14 2004-10-06 グラクソ、ウェルカム、インコーポレーテッド ベクロメタゾンジプロピオネート用計量投与用吸入器
EP1870122A3 (en) * 1995-04-14 2008-03-12 SmithKline Beecham Corporation Metered dose inhaler

Also Published As

Publication number Publication date
AU7496298A (en) 1998-12-11
NZ500874A (en) 2001-09-28
NO327716B1 (no) 2009-09-14
HU226694B1 (en) 2009-06-29
CZ412499A3 (cs) 2000-02-16
PL336885A1 (en) 2000-07-17
DE69816811T2 (de) 2004-04-15
JP2001526685A (ja) 2001-12-18
SK283930B6 (sk) 2004-05-04
CN1257421A (zh) 2000-06-21
HUP0002691A3 (en) 2001-04-28
AU726835B2 (en) 2000-11-23
ES2205491T3 (es) 2004-05-01
JP2016169222A (ja) 2016-09-23
BR9809448A (pt) 2000-06-20
PT983058E (pt) 2003-12-31
JP6178459B2 (ja) 2017-08-09
HUP0002691A2 (hu) 2001-02-28
BG103902A (en) 2000-05-31
KR100527643B1 (ko) 2005-11-15
JP2011102301A (ja) 2011-05-26
IL132738A0 (en) 2001-03-19
NO2009024I1 (no) 2009-10-26
EA002381B1 (ru) 2002-04-25
NO2009024I2 (no) 2010-08-16
JP6087882B2 (ja) 2017-03-01
CA2290521C (en) 2006-10-10
EA199900991A1 (ru) 2000-08-28
CN1149073C (zh) 2004-05-12
UA58551C2 (uk) 2003-08-15
HK1027027A1 (en) 2001-01-05
SK157699A3 (en) 2000-05-16
NO995667L (no) 1999-11-18
CZ298253B6 (cs) 2007-08-08
EP0983058B1 (en) 2003-07-30
NO995667D0 (no) 1999-11-18
YU59899A (sh) 2002-06-19
BG64268B1 (bg) 2004-08-31
DE69816811D1 (de) 2003-09-04
DK0983058T3 (da) 2003-11-24
CA2290521A1 (en) 1998-11-26
EP0983058A1 (en) 2000-03-08
KR20010012810A (ko) 2001-02-26
WO1998052542A1 (en) 1998-11-26
PL191523B1 (pl) 2006-06-30
ME01631B (me) 2007-08-03
TR199902863T2 (xx) 2000-05-22
IL132738A (en) 2004-06-20
ATE245966T1 (de) 2003-08-15
JP2015024999A (ja) 2015-02-05
US6120752A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
RS49628B (sr) Medicinski aerosolni proizvodi
CY1107899T1 (el) 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειϊκο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας
ATE306261T1 (de) Antithrombosemittel
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
IL133623A0 (en) Antithrombotic agents
ATE229802T1 (de) Zusammenstellung aus gemischten cyanoacrylatestern
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
ATE269312T1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
YU56995A (sh) Soli derivata indola
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
WO2003076417A3 (en) Oxo-azabicyclic compounds
DE60322200D1 (de) Formoterol und ciclesonid aerosol-formulierungen
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
HUP0004058A2 (hu) Készítmények és eljárások biológiai membránok permeabilitásának reverzibilis növelésére
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
BR9507135A (pt) Composto uso do mesmo processo de preparação do mesmo composição farmacêutica e composição cosmética
WO2000007580A3 (en) Pharmaceutical compositions against autoimmune diseases
YU29299A (sh) Steroidi supstituisani u položaju 11, postupak njihovog dobijanja, njihova primena kod lekova i farmaceutski preparati koji ih sadrže
ES2131219T3 (es) Solvatos estables de compuestos de avermectina.